Advertisement
Search for

Volume 137, Issue 1, Pages 101-109 (July 2009)


View previous. 37 of 80 View next.

Video AbstractFrequency of Mitochondrial Defects in Patients With Chronic Intestinal Pseudo-Obstruction

Aurélien Amiot§, Maya Tchikviladzé, Francisca Joly, Abdelhamid Slama, Dominique Cazals Hatem#, Claude Jardel§⁎⁎, Bernard Messing, Anne Lombès§⁎⁎‡‡Corresponding Author Informationemail address

Received 17 December 2008; accepted 23 March 2009. published online 03 April 2009.

Background & Aims

Chronic intestinal pseudo-obstruction (CIPO) is a rare disorder caused by intestinal dysmotility and characterized by chronic symptoms suggesting bowel obstruction in the absence of fixed, occluding lesions. CIPO has been associated with primary defects of the mitochondrial oxidative phosphorylation pathway, although the frequency of mitochondrial disorders in patients with CIPO is unknown. This study evaluates mitochondrial function in patients with CIPO.

Methods

A retrospective study was performed of data collected from 80 CIPO patients at a tertiary centre over a 25-year period. Mitochondrial disorders were detected by analysis of serum lactate and thymidine phosphorylase activities, brain magnetic resonance images, and muscle biopsies. Genes encoding thymidine phosphorylase, mitochondrial DNA tRNAleu(UUR) or tRNAlys, and DNA polymerase-γ were analyzed for mutations.

Results

Mitochondrial defects were identified in 15 patients (10 women; median age at diagnosis 32 years), representing 19% of the study cohort. All 15 patients had extra-digestive symptoms, 5 had mutations in the thymidine phosphorylase gene, 2 had mutations in tRNAleu(UUR), and 5 had mutations in the DNA polymerase-γ gene. No genetic defect was detected in 3 of the patients with mitochondrial disorders. Patients with mitochondrial CIPO differed from patients without mitochondrial defects in their very severe nutritional status (frequent and long-term requirement for parenteral nutrition) and poor prognosis (frequent digestive and neurologic complications that led to a high incidence of premature death).

Conclusion

Mitochondrial disorders seem to be an important cause of CIPO. Patients with CIPO, especially severe cases with associated neurologic symptoms, should be tested for mitochondrial defects.

 AP-HP, Hôpital Beaujon, Pôle des maladies de l'appareil digestif, Service de Gastroentérologie et d'assistance nutritive, Clichy, France

 Université Paris Diderot-Paris, Paris, France

§ INSERM, U975, Hôpital de La Salpêtrière, Paris, France

 AP-HP, Hôpital de La Salpêtrière, Centre de référence des maladies neuromusculaires, Paris, France

 AP-HP, Hôpital Bicêtre, Service de Biochimie, Le Kremlin-Bicêtre, France

# AP-HP, Hôpital Beaujon, Service d'anatomie pathologique, Clichy, France

⁎⁎ AP-HP, Hôpital de La Salpêtrière, Service de Biochimie Métabolique, Paris, France

‡‡ Université Pierre et Marie Curie-Paris 6 UPMC-Paris 6, Paris, France

Corresponding Author InformationReprint requests Address requests for reprints to: Anne Lombès, MD, PhD, INSERM 975, Hôpital Pitié-Salpêtrière,75651 Paris Cedex 13, France; fax: +331 40 16 57 00

 To view this article's video abstract, go to the AGA's YouTube Channel.

 Conflicts of interest The authors disclose no conflicts.

 Funding Aurélien Amiot was the recipient of a fellowship from Sanofi-Aventis. The work was supported by grant from the Association Française contre les myopathies (AFM).

PII: S0016-5085(09)00518-6

doi:10.1053/j.gastro.2009.03.054


View previous. 37 of 80 View next.

Advertisement